Explore 3 Stock Ideas & Industry Insights Download Free Report

News

US Sector Performance Analysis: Tech Wreck Wipes Out Growth as Capital Stampedes into Defensive Safety

The USEquitymarket on June 5, 2026, was defined by a historic and violent capital rotation. The session witnessed a brutal, indiscriminateLiquidationof the Technology sector, triggering a shockwave that completely rewired the S&Amp;P 500's structural architecture. As trillions of dollars in mega-capMarket Valueevaporated, institutional desks …

Robert Luong | 07 June 2026

US Sector Momentum Analysis: The Ironclad Barbell and the Great Consumer Divergence

The USEquitymarket structure has defied broader macroeconomicVolatilityto forge an incredibly resilient, dual-engine architecture. Heading into the new trading week, the Relative Rotation Graph (RRG) reveals that institutionalCapitalhas cemented an "Ironclad Barbell," simultaneously underwriting the secular growth of Information Technology (XLK) and the sovereign defensive …

Robert Luong | 07 June 2026

Advanced Micro Devices (NASDAQ:AMD) Chases Nvidia as the AI Chip Race Heats Up

In the race to power the artificial-intelligence revolution, one company stands as the most credible challenger to the dominant chip designer: Advanced Micro Devices (Nasdaq:AMD). Once an underdog in the processor market, AMD has clawed its way into contention across data centers and is …

Nitish Kishor | 05 June 2026

Walmart's Retail Strength and Digital Growth Keep the Consumer Giant in Focus

Walmart (Nasdaq:WMT) has spent decades as the dominant force in American retail, but in recent years it has reinvented itself into something more: a digital and advertising powerhouse layered on top of the world's largest store network. As consumers seek value and convenience, Walmart's …

Nitish Kishor | 05 June 2026

AstraZeneca (NYSE:AZN) Stock Outlook: Oncology Pipeline Drives Growth and Valuation Debate

AstraZeneca (NYSE:AZN) has transformed itself over the past decade into one of the world's leading pharmaceutical companies, powered by a deep and productive pipeline of new medicines, particularly in oncology. With ambitious long-term growth targets and a steady stream of pipeline readouts, the company …

Nitish Kishor | 05 June 2026